Data Driven Approaches to Repurposing

Abstract

AstraZeneca's Indication Discovery team is using cutting-edge technologies to revolutionize the drug discovery process and improve patient outcomes. By generating Omics signatures for their molecules and using AI and Bioinformatic systems to predict novel connections, we are pushing the boundaries of drug discovery and changing the way medicines are delivered to patients. This talk will focus on a background to these systems and examples of how we are using the outputs.